42 related articles for article (PubMed ID: 21554106)
21. The role of glutathione in the permeation enhancing effect of thiolated polymers.
Clausen AE; Kast CE; Bernkop-Schnürch A
Pharm Res; 2002 May; 19(5):602-8. PubMed ID: 12069161
[TBL] [Abstract][Full Text] [Related]
22. An oral oligonucleotide delivery system based on a thiolated polymer: Development and in vitro evaluation.
Martien R; Hoyer H; Perera G; Schnürch AB
Eur J Pharm Biopharm; 2011 Aug; 78(3):355-60. PubMed ID: 21295141
[TBL] [Abstract][Full Text] [Related]
23. In vitro evaluation of the permeation-enhancing effect of thiolated polycarbophil.
Clausen AE; Bernkop-Schnürch A
J Pharm Sci; 2000 Oct; 89(10):1253-61. PubMed ID: 10980500
[TBL] [Abstract][Full Text] [Related]
24. Labrasol
Heade J; Maher S; Bleiel SB; Brayden DJ
J Pharm Sci; 2018 Jun; 107(6):1648-1655. PubMed ID: 29462634
[TBL] [Abstract][Full Text] [Related]
25. A mucoadhesive nanoparticulate system for the simultaneous delivery of macromolecules and permeation enhancers to the intestinal mucosa.
Makhlof A; Werle M; Tozuka Y; Takeuchi H
J Control Release; 2011 Jan; 149(1):81-8. PubMed ID: 20138935
[TBL] [Abstract][Full Text] [Related]
26. Safety concerns over the use of intestinal permeation enhancers: A mini-review.
McCartney F; Gleeson JP; Brayden DJ
Tissue Barriers; 2016; 4(2):e1176822. PubMed ID: 27358756
[TBL] [Abstract][Full Text] [Related]
27. Oral drug absorption enhancement by chitosan and its derivatives.
Thanou M; Verhoef JC; Junginger HE
Adv Drug Deliv Rev; 2001 Nov; 52(2):117-26. PubMed ID: 11718935
[TBL] [Abstract][Full Text] [Related]
28. SNAC for Enhanced Oral Bioavailability: An Updated Review.
Kommineni N; Sainaga Jyothi VGS; Butreddy A; Raju S; Shapira T; Khan W; Angsantikul P; Domb AJ
Pharm Res; 2023 Mar; 40(3):633-650. PubMed ID: 36539668
[TBL] [Abstract][Full Text] [Related]
29. Gastrointestinal Permeation Enhancers for the Development of Oral Peptide Pharmaceuticals.
Kim JC; Park EJ; Na DH
Pharmaceuticals (Basel); 2022 Dec; 15(12):. PubMed ID: 36559036
[TBL] [Abstract][Full Text] [Related]
30. Intestinal Permeation Enhancers for Oral Delivery of Macromolecules: A Comparison between Salcaprozate Sodium (SNAC) and Sodium Caprate (C
Twarog C; Fattah S; Heade J; Maher S; Fattal E; Brayden DJ
Pharmaceutics; 2019 Feb; 11(2):. PubMed ID: 30781867
[TBL] [Abstract][Full Text] [Related]
31. Gastrointestinal absorption of heparin by lipidization or coadministration with penetration enhancers.
Ross BP; Toth I
Curr Drug Deliv; 2005 Jul; 2(3):277-87. PubMed ID: 16305430
[TBL] [Abstract][Full Text] [Related]
32. Application of Permeation Enhancers in Oral Delivery of Macromolecules: An Update.
Maher S; Brayden DJ; Casettari L; Illum L
Pharmaceutics; 2019 Jan; 11(1):. PubMed ID: 30669434
[TBL] [Abstract][Full Text] [Related]
33. Thiolated polycarbophil/glutathione: defining its potential as a permeation enhancer for oral drug administration in comparison to sodium caprate.
Perera G; Barthelmes J; Vetter A; Krieg C; Uhlschmied C; Bonn GK; Bernkop-Schnürch A
Drug Deliv; 2011 Aug; 18(6):415-23. PubMed ID: 21554106
[TBL] [Abstract][Full Text] [Related]
34. Permeation enhancing polymers in oral delivery of hydrophilic macromolecules: thiomer/GSH systems.
Bernkop-Schnürch A; Kast CE; Guggi D
J Control Release; 2003 Dec; 93(2):95-103. PubMed ID: 14636716
[TBL] [Abstract][Full Text] [Related]
35. Intestinal absorption enhancement via the paracellular route by fatty acids, chitosans and others: a target for drug delivery.
Cano-Cebrián MJ; Zornoza T; Granero L; Polache A
Curr Drug Deliv; 2005 Jan; 2(1):9-22. PubMed ID: 16305404
[TBL] [Abstract][Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
